Victory Capital Management
PLSE icon

Victory Capital Management’s Pulse Biosciences PLSE Stock Holding History

Victory Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,034
Closed -$28K – 3069
2020
Q1 		$28K Buy
+4,034
New +$41.9K ﹤0.01% 2982
2019
Q4 		– Sell
-2,088
Closed -$32K – 3092
2019
Q3 		$32K Buy
+2,088
New +$27.1K ﹤0.01% 2881

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Victory Capital Management's PLSE Position: Q2 2020 in Review

Victory Capital Management sold out of Pulse Biosciences (PLSE) in Q2 2020, closing a stake of 4,034 shares — an estimated $28K sold.

Victory Capital Management first reported a position in PLSE in Q3 2019 and held it in 2 quarters. The position peaked at $32K in Q3 2019. 51 funds tracked by Wall St. Rank hold PLSE as of Q2 2020.

  • Victory Capital Management reported no remaining Pulse Biosciences position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 4,034 Pulse Biosciences shares in Q2 2020, an estimated $28K.
  • Victory Capital Management first reported a position in Pulse Biosciences in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Pulse Biosciences position peaked at $32K in Q3 2019.
  • 51 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.